View of Does the prophylactic use of Palivizumab in premature patients with Down Syndrome in respiratory syncytial virus infection reduce the hospitalization rate? An integrative review

Return to Article Details Does the prophylactic use of Palivizumab in premature patients with Down Syndrome in respiratory syncytial virus infection reduce the hospitalization rate? An integrative review Download Download PDF